Friday, October 23, 2009

Wound Healing Honey to be Discussed at U.S. Conference

Derma Sciences Announces Multiple Clinical Presentations of MEDIHONEY(R) at Upcoming Major Wound Care Conference
11 Separate Clinical Case Series Presentations on a Variety of Wound Types Further Broadens the Evidence Base of the Company's Key Product

PRINCETON, N.J., Oct. 21 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a specialty medical device/pharmaceutical company focusing on advanced wound care, today announced that eleven clinical case series regarding its flagship product, MEDIHONEY®, will be presented at the upcoming October 22-25 Clinical Symposium on Advances in Skin & Wound Care in San Antonio. These presentations include:

· "Active Leptospermum Honey and Negative Pressure Wound Therapy for Non-Healing Post-Surgical Wounds"

· "Honey Under Negative Pressure Wound Therapy: A New Approach to Removing Devitalized Tissue"

· "Use of Honey Dressings for Infected Left Ventricular Assist Device Wounds"

· "Evidence Based Practice for Pediatric Wound Care: Utilizing Active Leptospermum Honey as a Primary Dressing for Chronic Wounds"

· "Active Leptospermum Honey for Pediatric Wound Care: Moving Evidence into Practice"

· "The Clinical Benefits of Active Leptospermum Honey: Oncologic Wounds"

· "Active Leptospermum Honey for Frostbite, PIN Sites, and Skin Tears"

· "Utilizing Active Leptospermum Honey Dressings in the Treatment of Cutaneous Small Vessel Vasculitis"

· "Active Leptospermum Honey for the Treatment of Recalcitrant Lower Extremity Wounds"

· "Use of Active Leptospermum Honey Dressings in the Home Care Setting"

· "Evidence Based Practice: Active Leptospermum Honey Dressings for Tertiary Care"

No comments: